L. Andersen

C. Godballe, C. Kristensen, K. Bjørndal, 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Malignant Warthin's tumour: a case study

L. Andersen, M. Katholm, M. Therkildsen, 1992, Histopathology.

The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.

J. Overgaard, J. Johansen, C. Kristensen, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.

Jens Overgaard, J. Overgaard, J. Johansen, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.

J. Overgaard, S. Dalton, J. Johansen, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

Cai Grau, Jens Overgaard, Lena Specht, 2003, The Lancet.

Malignant melanoma of the upper respiratory tract and the oral cavity.

A. Berthelsen, L. Andersen, H. S. Hansen, 1992, The Journal of otolaryngology.

Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer

H. von der Maase, L. Sengeløv, P. Geertsen, 2000, Cancer Chemotherapy and Pharmacology.

Subglottic squamous cell carcinoma in Denmark 1971–2015 – a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group

J. Overgaard, J. Johansen, C. Kristensen, 2019, Acta oncologica.

Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group.

J. Overgaard, J. Johansen, C. Kristensen, 2016, European journal of cancer.

Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group.

J. Overgaard, J. Johansen, A. R. Jensen, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study

J. Overgaard, J. Eriksen, K. Toustrup, 2015, Acta oncologica.

DAHANCA 9 – a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)

J. Overgaard, H. Sand Hansen, J. Johansen, 2019, Acta oncologica.

Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy.

Cai Grau, Christian Rønn Hansen, C. Hansen, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Salivary adenoid cystic carcinoma in Denmark 1990-2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA).

C. Godballe, J. Johansen, C. Kristensen, 2015, Oral oncology.

Polymorphous low-grade adenocarcinoma: A Danish national study.

C. Godballe, C. Kristensen, K. Bjørndal, 2016, Oral oncology.

The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial.

L. Specht, C. Grau, J. Overgaard, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cisplatin, methotrexate and mitoxantrone in patients with metastatic or advanced urothelial cancer.

H. von der Maase, L. Sengeløv, L. Andersen, 1998, Acta oncologica.

Does age affect prognosis in salivary gland carcinoma patients? A national Danish study

J. Overgaard, C. Godballe, J. Johansen, 2016, Acta oncologica.

OC-009: Update of the randomised phase III trial DAHANCA 19: Primary C-RT or RT and zalutumumab for squamous cell carcinomas of head and neck

J. Overgaard, J. Johansen, C. Kristensen, 2015 .

DAHANCA 9: a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck

J. Overgaard, J. Johansen, M. Overgaard, 2013 .

Oncocytic carcinoma of the salivary glands: A Danish national study.

C. Godballe, C. Kristensen, M. Westergaard-Nielsen, 2017, Auris, nasus, larynx.

OC-0372: DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas

J. Overgaard, J. Johansen, C. Kristensen, 2014 .

Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: A Danish nationwide survey from DAHANCA

C. Grau, J. Overgaard, H. Sand Hansen, 2006, Acta oncologica.

Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer

L. Bastholt, L. Specht, C. Grau, 2003 .

Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer

L. Specht, C. Grau, J. Overgaard, 2013, Acta oncologica.

The management and survival outcomes of nasopharyngeal cancer in the Nordic countries*

H. Minn, H. Joensuu, S. Friesland, 2017, Acta oncologica.

COMORBIDITY AMONG 13,651 HEAD AND NECK CANCER PATIENTS FROM THE DAHANCA-DATABASE

J. Overgaard, S. Dalton, J. Johansen, 2011 .